uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted August 21, 2014

Seller of Joint Supplement Warned for Manufacturing Violations and Drug Claims

On July 17, 2014, the FDA issued a warning letter to Klein Laboratories, Inc., following a facility inspection which found the company's joint pain supplement, Osteojuv, to be adulterated because it was prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at